The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent ...

Philips will sell its emergency care business to investment firm Bridgefield Capital for an undisclosed amount. The deal is ...

The Philips HeartStart OnSite Defibrillator is designed to be the easiest-to-use, and most reliable defibrillator available. Available without a prescription from ActiveForever.com, the Philips ...

Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, ...

SAN FRANCISCO, Jan 13 (Reuters) - Philips (PHG.AS), opens new tab CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare anti-corruption efforts by the Chinese ...

Nasdaq MRX (MRX) offers both a simple customer priority, pro-rata allocation market, and a price-time complex market, complete with a full suite of auction and crossing orders. MRX follows a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Marex Group ( NASDAQ:MRX ) Third Quarter 2024 Results Key Financial Results Revenue: US$327.7m (down 9.1% from 3Q... Marex Group PLC (MRX) reports a 32% revenue increase and raises full-year ...

Marex Group Plc provides brokerage services for commodities, financials, and foreign exchange. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment ...

The FDA announced today that a Philips (NYSE: PHG) + recall involving remote cardiac monitoring software is Class I, its most serious recall designation. On Dec. 18, 2024, Philips and its ...

Philips is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of healthcare, consumer lifestyle and lighting. Philips makes ...